Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

JPAS. 2018; 15(1): 18-22


EFFECT OF CONTROLLED-DIET IN THE TREATMENT OF CARBON TETRACHLORIDE-INDUCED HEPATOTOXIC RATS

Misbahu Sambo, Abdulqadir Yunusa, Atiku Muhammad Kano.




Abstract

ABSTRACT
The aim of this study was to investigate the effect of controlled-diet in the treatment of rats with hepatotoxicity caused by CCl4. The serum level of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, direct bilirubin, and total bilirubin was measured using standard methods and compared among group I (Normal control), group II (CCl4 control; hepatotoxic rats without treatment), group III (Hepatotoxic rats treated with 5.2 mg/kg of standard drug only), and group IV (Hepatotoxic rats treated with 5.2 mg/kg of standard drug + controlled diet). The result showed that the level of the biochemical parameters was significantly lower (p < 0.05) in group III compared with group II. However, the result showed no significant difference (p > 0.05) in the level of measured biochemical parameters between groups III and IV. These results reaffirm the hepatocurative effect of the standard drug (Livolin). It also indicates that the controlled diet used in this research has no positive (curative) effect in the treatment of liver disease.

Key words: Key words: Carbon tetrachloride, Controlled-diet, Livolin, Liver disease






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.